Niagen Bioscience, Inc. (NAGE)
2.47
-0.04
(-1.59%)
USD |
NASDAQ |
Oct 21, 16:00
2.455
-0.02
(-0.61%)
After-Hours: 20:00
Niagen Bioscience Gross Profit Margin (Quarterly) : 64.84% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 64.84% |
| March 31, 2026 | 63.47% |
| December 31, 2025 | 64.14% |
| September 30, 2025 | 64.52% |
| June 30, 2025 | 65.00% |
| March 31, 2025 | 63.42% |
| December 31, 2024 | 62.48% |
| September 30, 2024 | 63.49% |
| June 30, 2024 | 60.22% |
| March 31, 2024 | 60.74% |
| December 31, 2023 | 61.04% |
| September 30, 2023 | 61.40% |
| June 30, 2023 | 60.80% |
| March 31, 2023 | 59.93% |
| December 31, 2022 | 57.23% |
| September 30, 2022 | 59.82% |
| June 30, 2022 | 60.02% |
| March 31, 2022 | 61.02% |
| December 31, 2021 | 61.20% |
| September 30, 2021 | 61.12% |
| June 30, 2021 | 61.08% |
| March 31, 2021 | 62.89% |
| December 31, 2020 | 61.00% |
| September 30, 2020 | 59.62% |
| June 30, 2020 | 59.45% |
| Date | Value |
|---|---|
| March 31, 2020 | 57.94% |
| December 31, 2019 | 57.03% |
| September 30, 2019 | 55.99% |
| June 30, 2019 | 56.34% |
| March 31, 2019 | 52.76% |
| December 31, 2018 | 51.96% |
| September 30, 2018 | 53.71% |
| June 30, 2018 | 49.29% |
| March 31, 2018 | 47.77% |
| December 31, 2017 | 50.92% |
| September 30, 2017 | 47.91% |
| June 30, 2017 | 50.00% |
| March 31, 2017 | 48.04% |
| December 31, 2016 | 45.14% |
| September 30, 2016 | 47.32% |
| June 30, 2016 | 46.74% |
| March 31, 2016 | 47.07% |
| December 31, 2015 | 36.68% |
| September 30, 2015 | 39.47% |
| June 30, 2015 | 40.49% |
| March 31, 2015 | 36.64% |
| December 31, 2014 | 33.44% |
| September 30, 2014 | 36.79% |
| June 30, 2014 | 36.27% |
| March 31, 2014 | 32.04% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Cyanotech Corp. | 42.38% |
| Mannatech, Inc. | 75.90% |
| Natural Alternatives International, Inc. | 4.22% |
| USANA Health Sciences, Inc. | 74.91% |
| Nature's Sunshine Products, Inc. | 70.84% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 21.25% |
| Return on Assets | 15.47% |
| Return on Invested Capital | 20.48% |
| Profit Margin (Quarterly) | 3.23% |
| Operating Margin (Quarterly) | 2.35% |
| Return on Net Operating Assets | 43.57% |